Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
05/2000
05/31/2000EP1003888A2 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
05/31/2000EP1003886A1 Chimeric transcriptional activators and compositions and uses related thereto
05/31/2000EP1003878A2 Hiv-1 group o antigens and uses thereof
05/31/2000EP1003874A1 Neisseria lactoferrin binding protein
05/31/2000EP1003861A2 Mammalian cell membrane proteins; related reagents
05/31/2000EP1003859A1 Use of transcription factor brn-3a
05/31/2000EP1003851A2 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy
05/31/2000EP1003850A1 Inhibitors of dna immunostimulatory sequence activity
05/31/2000EP1003848A2 Methods for activating inactive genes and methods for altering the rate of development of cells, tissues and organisms
05/31/2000EP1003784A1 Novel peptides and polypeptides useful for regenerating the nervous system
05/31/2000EP1003783A2 Lipoprotein-regulating medicaments
05/31/2000EP1003781A1 Interleukin-18 binding proteins, their preparation and use
05/31/2000EP1003780A1 Human f11 antigen: a cell surface receptor involved in platelet aggregation
05/31/2000EP1003776A1 Gene and amino acid sequences for novel transcription factor
05/31/2000EP1003773A1 Ctl epitopes from ebv
05/31/2000EP1003769A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same
05/31/2000EP1003763A1 83 human secreted proteins
05/31/2000EP1003711A1 Novel lipopolyamines, and the preparation and use thereof
05/31/2000EP1003558A1 Lipid-polyamide conjugates and compositions for nucleic acid delivery
05/31/2000EP1003556A2 Cationic reagents for transfection
05/31/2000EP1003543A1 Apoptosis-inducing gelsolin sequences
05/31/2000EP1003533A1 Use of herpes vectors for tumor therapy
05/31/2000EP1003531A1 Vectors and methods for immunization or therapeutic protocols
05/31/2000EP1003527A1 Polynucleotide compositions
05/31/2000EP1003500A1 Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
05/31/2000EP1003365A1 Atrial natriuretic factor mutants and ischemic stroke
05/31/2000CN1255163A Compounds
05/31/2000CN1255067A Use of secretion vector for fertility control by oral vaccination
05/31/2000CN1254756A Attenuated virus of ox's viral diarrhea
05/31/2000CN1052915C Protein coating as medical carrier for carrying gene and its preparing process
05/30/2000US6069297 Glucose-6-phosphate dehydrogenase deficient mice and methods of using same
05/30/2000US6069239 Expression system present in compatible host cell which produces a ligand regulated transcription factor; antiinflammatory/antiarthritic/antidiabetic agents; treatment of autoimmune diseases; diagnosis of related diseases
05/30/2000US6069231 Amino acid sequences of domains found in transcription factors including a mammalian retinoblastoma-interacting zinc finger protein; for fusion proteins useful for regulating transcription of target genes; diagnosis of related diseases
05/30/2000US6069134 Methods and compositions comprising DNA damaging agents and p53
05/30/2000US6069133 Targeted delivery of genes encoding interferon
05/30/2000US6069006 Connective tissue growth factor (CTGF) regulatory nucleic acid sequences
05/30/2000US6069001 Nucleotide sequence; for use in diagnosis of cancer and melanoma; for use in human leukocyte antigen typing for grafts and transplants
05/30/2000US6068990 Proteins, their production and use
05/30/2000US6068983 Introducing into cells a dna molecule coding for an fc receptor which is then expressed for increased phagocytic activity; combating infection and/or modulating immune complex disease
05/30/2000US6068837 Mesothelial cell gene therapy
05/30/2000US6068836 Providing a population of pluripotent hematopoetic cells, expanding population of stem cells to yield expanded stem cells, inducing a majority of cells in the population of expanded cells to become quiescent, using quiescent cells
05/25/2000WO2000029623A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
05/25/2000WO2000029622A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
05/25/2000WO2000029602A1 Transfection of male germ cells for generation of selectable transgenic stem cells
05/25/2000WO2000029601A1 A method for depopulating of vertebrate testis and for generation of transgenic species
05/25/2000WO2000029600A1 Systemic viral/ligand gene delivery system and gene therapy
05/25/2000WO2000029599A1 Viral vectors with late transgene expression
05/25/2000WO2000029598A1 Novel recombinant adenovirus
05/25/2000WO2000029589A1 Methioninase gene therapy for tumor treatment
05/25/2000WO2000029582A2 Cell surface receptor antigen vaccines
05/25/2000WO2000029578A1 Cloning and characterization of two m-rna transcription factors
05/25/2000WO2000029574A2 Inflammation-associated genes
05/25/2000WO2000029573A2 Adenoviral vectors
05/25/2000WO2000029571A1 Gene encoding novel transmembrane protein
05/25/2000WO2000029569A1 Methods of diagnosing or treating neurological diseases
05/25/2000WO2000029564A2 Human glycine transporter type 2
05/25/2000WO2000029550A2 Low oxygen culturing of central nervous system progenitor cells
05/25/2000WO2000029549A2 Low oxygen culturing of cells
05/25/2000WO2000029443A1 Contraceptive antibody vaccines
05/25/2000WO2000029438A1 Egf-like nucleic acids and polypeptides and uses thereof
05/25/2000WO2000029435A1 12 human secreted proteins
05/25/2000WO2000029431A1 Bispecific molecules cross-linking itim and itam for therapy
05/25/2000WO2000029428A2 5t4 tumour-associated antigen for use in tumour immunotherapy
05/25/2000WO2000029422A1 31 human secreted proteins
05/25/2000WO2000029033A2 A method of genetic vector delivery
05/25/2000WO2000029032A1 Methods for using heat shock proteins bound to dna or rna
05/25/2000WO2000029031A1 Nucleic acid transporters and medicinal compositions for gene therapy
05/25/2000WO2000029024A1 Formulation of adenovirus for gene therapy
05/25/2000WO2000029015A2 INFLUENCING OF ANGIGENESIS USING CD66a
05/25/2000WO2000029012A2 Methods of alleviating cancer symptoms
05/25/2000WO2000029002A2 In utero transplantation of human mesenchymal stem cells
05/25/2000WO2000018920A3 Tmof receptor and uses thereof
05/25/2000WO2000017233A3 Genes of the 1-desoxy-d-xylulose biosynthetic pathway
05/25/2000WO2000015798A3 Mammalian transforming growth factor beta - 9 (ztgfss9)
05/25/2000WO2000015788A3 Dna sequence encoding oncofetal ferritin protein
05/25/2000WO2000014228A8 Neutral amino acid transporter and gene thereof
05/25/2000WO2000009148A9 Vascular endothelial growth factor 3
05/25/2000WO2000008194A3 Cell lines for the propagation of mutated herpes viruses
05/25/2000WO2000008153A3 Arf-p19, a novel regulator of the mammalian cell cycle
05/25/2000WO2000004051A3 Growth differentiation factor promoter and uses therefor
05/25/2000WO1999026644A9 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
05/25/2000WO1998049350A8 In vivo use of recombinagenic oligonucleobases to correct genetic lesions in hepatocytes
05/25/2000DE19850986A1 Die gentechnische Prägung von Zellen und ihre Verwendung zur Prophylaxe und Therapie von Erkrankungen The genetic imprint of cells and their use in the prophylaxis and treatment of diseases
05/25/2000CA2356926A1 Methioninase gene therapy for tumor treatment
05/25/2000CA2351729A1 Cell surface receptor antigen vaccines
05/25/2000CA2351629A1 Nucleic acid carriers and pharmaceutical compositions for gene therapy
05/25/2000CA2351622A1 Polypeptide
05/25/2000CA2351585A1 Influencing of angigenesis using cd66a
05/25/2000CA2351576A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
05/25/2000CA2351522A1 Egf-like nucleic acids and polypeptides and uses thereof
05/25/2000CA2351314A1 Novel recombinant adenovirus
05/25/2000CA2351161A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
05/25/2000CA2350917A1 Contraceptive antibody vaccines
05/25/2000CA2350890A1 Aqueous compositions for long-term stable storage of adenovirus particles including uses and methods for preparing same
05/25/2000CA2350785A1 31 human secreted proteins
05/25/2000CA2350698A1 Human glycine transporter type 2
05/25/2000CA2350415A1 Inflammation-associated genes
05/25/2000CA2349238A1 Systemic viral/ligand gene delivery system and gene therapy
05/25/2000CA2348824A1 12 human secreted proteins
05/24/2000EP1002870A1 Androgen- and progesteron-receptor binding Hormone Response Element
1 ... 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 ... 870